1. Home
  2. ULTA vs UTHR Comparison

ULTA vs UTHR Comparison

Compare ULTA & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ulta Beauty Inc.

ULTA

Ulta Beauty Inc.

N/A

Current Price

$513.77

Market Cap

23.8B

ML Signal

N/A

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

N/A

Current Price

$532.91

Market Cap

23.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ULTA
UTHR
Founded
1990
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.8B
23.9B
IPO Year
2007
1999

Fundamental Metrics

Financial Performance
Metric
ULTA
UTHR
Price
$513.77
$532.91
Analyst Decision
Buy
Buy
Analyst Count
23
14
Target Price
$669.38
$531.79
AVG Volume (30 Days)
736.9K
523.9K
Earning Date
03-12-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
13.07
EPS
17.65
27.86
Revenue
$11,295,654,000.00
$1,483,300,000.00
Revenue This Year
$7.50
$7.05
Revenue Next Year
$4.80
$13.30
P/E Ratio
$29.93
$18.85
Revenue Growth
0.79
2.38
52 Week Low
$347.48
$266.98
52 Week High
$714.97
$548.12

Technical Indicators

Market Signals
Indicator
ULTA
UTHR
Relative Strength Index (RSI) 23.91 58.52
Support Level $509.07 $464.92
Resistance Level $535.09 $542.66
Average True Range (ATR) 20.89 13.48
MACD -11.01 -0.51
Stochastic Oscillator 8.53 80.20

Price Performance

Historical Comparison
ULTA
UTHR

About ULTA Ulta Beauty Inc.

Ulta Beauty is the largest specialized beauty retailer in the US with about 1,500 freestanding stores. The firm offers cosmetics (39% of 2024 sales), fragrances (13%), skin care (23%), and hair care products (19%). It also has salon services, including hair, makeup, skin, and brow, that account for about 4% of its revenue and drive traffic. Outside of the US, Ulta acquired premium beauty retailer Space NK and its 83 stores in the UK and Ireland in 2025, is opening franchised stores in Mexico, and has formed a joint venture to expand into the Middle East. In addition, Ulta collects royalties through its Target partnership (set to end in 2026) and credit card revenue. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Share on Social Networks: